Overview

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects

Status:
Completed

Trial end date:
2005-05-01

Target enrollment:

Participant gender:

Summary

An analysis of the costs and outcomes associated with hospitalization and treatment of Levalbuterol versus Racemic Albuterol in subjects with Asthma and COPD.

Phase:

Phase 4

Details

Lead Sponsor:

Sunovion

Treatments:

Albuterol
Pharmaceutical Solutions